About Enhancer
| Enhancer ID: | E_00405 |
| Species: | Homo sapiens |
| Position : | chr3:41172000-41174000   |
| Year: | 2021 |
| Title: | The osteoporosis risk variant rs9820407 at 3p221 acts as an allele-specific enhancer to regulate CTNNB1 expression by long-range chromatin loop formation |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | osteosarcoma |
| PMID: | 34461284 |
| MONDO: | MONDO:0005087 |
| Tissue: | Bone |
| Tissue Ontology ID: | UBERON:0001474 |
| Cell Source: | SaOS-2 |
| CVCL ID: | CVCL_0548 |
| Cell Type: | osteosarcoma cell |
| Cell Ontology ID: | CL:0000082 |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay |
| High Throughput Method: | Hi-C, ChIP-seq |
| Low Throughput Method: | Luciferase Reporter Assay, RT-RT-qPCR |
About Target Gene
| Target gene : | CTNNB1 |
About TF
| TF name : |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Expression of Target Genes for the Enhancer